Product Description
Experience the exquisite power of Paclitaxel (Protein-Bound Particle) for Injection Suspensioncrafted for invincible performance in oncology treatments. Get instant savings with our special, solvent-free formulation, utilizing imposing NAB technology to maximize cellular uptake. Each single-use vial contains 100 mg of lyophilized powder, to be reconstituted with 20 mL of 0.9% sodium chloride for intravenous infusion only. With a precise nanoparticle size (approx. 130 nm), it seamlessly integrates into standard IV sets. This preservative-free solution is exceptional for metastatic breast, non-small cell lung, and pancreatic cancer management. Special packaging safeguards efficacy and shelf life, ensuring quality delivered directly from Indias trusted sources.
Enhanced Features, Application, and User Base
Designed with advanced NAB technology, Paclitaxel (Protein-Bound Particle) for Injection Suspension enhances cellular absorption for optimum therapeutic action. Suitable for use by oncologists and healthcare professionals, it is specially intended for intravenous infusion in oncology wards and specialized cancer centers. Its solvent-free, preservative-free composition ensures safety and efficacy, making it a preferred choice for treating multiple malignancies.
Shipping, Market Reach, and Reliable Delivery
Our product is available at the lowest price, with stock ready for immediate dispatch from major Indian FOB ports. Paclitaxel (Protein-Bound Particle) for Injection Suspension is delivered securely, with specialized single-use vial packaging to maintain quality. We serve global markets across Asia, Africa, and Eastern Europe, ensuring rapid and reliable delivery for distributors, exporters, suppliers, and wholesalers.
FAQs of Paclitaxel(Protien-Bound Particle) For Injection Suspension:
Q: How should Paclitaxel (Protein-Bound Particle) for Injection Suspension be prepared and administered?
A: Reconstitute the lyophilized powder with 20 mL of 0.9% sodium chloride injection, and administer only via intravenous infusion using standard IV sets without DEHP. It is strictly for single use.
Q: What are the clinical indications for using this injection suspension?
A: Paclitaxel (Protein-Bound Particle) is indicated for chemotherapy treatment of metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer.
Q: When should the product be used after reconstitution?
A: The reconstituted suspension should be used immediately for optimal effectiveness and to prevent contamination, as it does not contain preservatives.
Q: Where can this product be stored, and what are the storage conditions?
A: Store the vial below 25C and protect it from light. Shelf life is 24 months when stored as recommended.
Q: What safety precautions are necessary during handling and administration?
A: This is a cytotoxic agent, so use protective equipment such as gloves, gown, and eye protection to avoid contact during preparation and administration.
Q: What makes this formulation special compared to conventional forms of Paclitaxel?
A: The nanoparticle albumin-bound (NAB) technology creates solvent-free, protein-bound particles, which enhance cellular uptake and reduce certain toxicities associated with traditional solvents.